Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1975 Mar;72(3):937–940. doi: 10.1073/pnas.72.3.937

Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.

G M Hahn, J Braun, I Har-Kedar
PMCID: PMC432437  PMID: 48253

Abstract

The sensitivity of cells exposed in vitro to the antibiotics bleomycin or adriamycin is only mildly increased at 41 degrees over that seen at 37 degrees. However, at 43 degrees a marked synergism between the effects of hyperthermia and drug is observed. This synergism can also be demonstrated to occur in solid tumors in vivo. Cells after bleomycin exposure at 37 degrees repair potentially lethal damage, and 43 degrees inhibits this repair. This inhibition may in part account also for the observed sensitization of the cells to bleomycin, but not to adriamycin, since for the latter no repair can be demonstrated. However, fluorescence measurements show that at 43 degrees much more adriamycin is able to enter the cells than at 37 degrees. The possible implications of the results for cancer treatment are discussed.

Full text

PDF
937

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcamone F., Franceschi G., Penco S., Selva A. Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Lett. 1969 Mar;(13):1007–1010. doi: 10.1016/s0040-4039(01)97723-8. [DOI] [PubMed] [Google Scholar]
  2. Bachur N. R., Cradock J. C. Daunomycin metabolism in rat tissue slices. J Pharmacol Exp Ther. 1970 Nov;175(2):331–337. [PubMed] [Google Scholar]
  3. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  4. Cavaliere R., Ciocatto E. C., Giovanella B. C., Heidelberger C., Johnson R. O., Margottini M., Mondovi B., Moricca G., Rossi-Fanelli A. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 1967 Sep;20(9):1351–1381. doi: 10.1002/1097-0142(196709)20:9<1351::aid-cncr2820200902>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  5. Giovanella B. C., Morgan A. C., Stehlin J. S., Williams L. J. Selective lethal effect of supranormal temperatures on mouse sarcoma cells. Cancer Res. 1973 Nov;33(11):2568–2578. [PubMed] [Google Scholar]
  6. Hahn G. M. Metabolic aspects of the role of hyperthermia im mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res. 1974 Nov;34(11):3117–3123. [PubMed] [Google Scholar]
  7. Hahn G. M., Ray G. R., Gordon L. F., Kallman R. F. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. J Natl Cancer Inst. 1973 Feb;50(2):529–533. doi: 10.1093/jnci/50.2.529. [DOI] [PubMed] [Google Scholar]
  8. Hahn G. M., Stewart J. R., Yang S. J., Parker V. Chinese hamster cell monolayer cultures. I. Changes in cell dynamics and modifications of the cell cycle with the period of growth. Exp Cell Res. 1968 Feb;49(2):285–292. doi: 10.1016/0014-4827(68)90179-1. [DOI] [PubMed] [Google Scholar]
  9. Hubbell W. L., McConnell H. M. Molecular motion in spin-labeled phospholipids and membranes. J Am Chem Soc. 1971 Jan 27;93(2):314–326. doi: 10.1021/ja00731a005. [DOI] [PubMed] [Google Scholar]
  10. Johnson H. A., Pavelec M. Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst. 1973 Apr;50(4):903–908. doi: 10.1093/jnci/50.4.903. [DOI] [PubMed] [Google Scholar]
  11. Ray G. R., Hahn G. M., Bagshaw M. A., Kurkjian S. Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents. Cancer Chemother Rep. 1973 Nov-Dec;57(4):473–475. [PubMed] [Google Scholar]
  12. Rockwell S., Kallman R. F. Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res. 1973 Feb;53(2):281–294. [PubMed] [Google Scholar]
  13. Terasima T., Takabe Y., Katsumata T., Watanabe M., Umezawa H. Effect of bleomycin on mammalian cell survival. J Natl Cancer Inst. 1972 Oct;49(4):1093–1100. [PubMed] [Google Scholar]
  14. Umezawa H., Maeda K., Takeuchi T., Okami Y. New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 1966 Sep;19(5):200–209. [PubMed] [Google Scholar]
  15. Yang S. J., Hahn G. M., Bagshaw M. A. Chromosome aberrations induced by thymidine. Exp Cell Res. 1966 Apr;42(1):130–135. doi: 10.1016/0014-4827(66)90326-0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES